The Irish economy is particularly vulnerable to US tariffs against the EU, as it exports relatively more to the US compared ...

The Trump administration's comprehensive healthcare and pharma policy agenda aims to transform the US healthcare landscape, ...

Novo Nordisk (NVO) is not concerned by the ongoing US trade war and the 25% tariff set to go into effect for pharmaceutical ...

The US Food and Drug Administration (FDA) said it has determined the shortage of semaglutide injection products, a glucagon-like peptide 1 (GLP-1) medication, is now resolved.

Pharma - STADA, a leading healthcare and pharmaceutical company in Consumer Healthcare, Generics and Specialty ...

Weight-loss drugs aren’t just slimming waists; they create a $100 billion market opportunity. With plenty up for grabs, ...

Still, Novo is steadfast in its goal to eventually become a leader in the space, the company’s EVP of rare disease, Ludovic ...

Hemab Therapeutics, a clinical-stage biotechnology company developing novel prophylactic therapeutics for serious, underserved bleeding and thrombotic disorders, today announced the first participant ...

Learn more about whether The Carlyle Group Inc. or Northern Trust Corporation is a better investment based on AAII's A+ ...